L3 4 Antibodies

Embed Size (px)

Citation preview

  • 8/7/2019 L3 4 Antibodies

    1/12

    Immunology

    [Page 1]

    Introduction

    Antibodies (Immunoglobulin / Ig)The major agents of the humoral immune responseGlycoproteinsMembrane-bound (acting as receptors) or soluble (secreted)Bi-functional molecules: Bind antigen (Ag) & bind to receptors on cells & bind complementEvery antibody has a highly specific binding site

    Structure

    Four polypeptide chains

    2 identical large chains (heavy) ~450AA, ( / K / E / H / I)2 identical small chains (light) ~250AA, (O /P)

    The different types ofheavy / light chain are encoded by different genes

  • 8/7/2019 L3 4 Antibodies

    2/12

    Immunology

    [Page 2]

    The heavy chains define the class of antibody and the properties they have:

    locus = IgMK locus = IgGE locus = IgAH locus = IgDI locus = IgE

    The ability to bind to antigens lies in the light chain

    The ability to bind to cells and activate the complement lies in the heavy chain (biological activity)

    Amino terminus is at the top of the Y

    Carboxyl terminus is at the bottom of the Y

    Heavy Chain:

    Each is broken up into 4 domains

    VHVariable heavyCH1-3 Constant heavy (3 domains)

    It is the constant regions that define the properties of the heavy chain, and therefore the properties of the antibody

    Separated by a hinge region which gives the antibody flexibility in the arms of the Y

    Connected by disulphide bonds

    Constant heavy domains are numbered from amino (1)p carboxyl (3)

    Every domain is stabilised by a single disulphide bond

    This stabilises the internal folding

    IgM and IgEhave no hinge region, and also have an additional CH domain (CH 4)

    Less flexibility for lateral movement

    Light Chain:

    Broken up into 2 domains:

    CLConstant lightVLVariable light

    The light chain is connected to the heavy chain by a single disulphide bond

    Each light chain is ~25 kDa (50 kDa total)

  • 8/7/2019 L3 4 Antibodies

    3/12

    Immunology

    [Page 3]

    Eachheavy chain is ~55 kDa (110 kDa total)

    An average antibody has a total MW of 160 kDa

    A reducing agent (F-mercaptoethanol) can be used to break disulphide bonds leaving 4 chains

    Antibodies are glycoproteins contain a carbohydrate part

    No known function other than to promote folding

  • 8/7/2019 L3 4 Antibodies

    4/12

    Immunology

    [Page 4]

    Proteolytic digestion was used to classify the antibodies

    They were digested into smaller parts, then analysed

    Papain cleaves the heavy chains to produce 3 molecules

    Fab = fragment antigen binding

    Determined that binding was monovalent, each Fab fragment

    bound a single antigen

    Fc = fragment crystallisable

    Fc is constant domain which is why it can be made into a

    crystal

    It is this region that activates the complement

    It is also this region that binds to receptors on cells

    Most cells of the immune system have FC receptors (FCR)

    The soluble antibody can bind the FCR

    There are different FCRs for the different classes of antibody

    All classes of IgG can cross the placenta in man

    There are receptors that bind the FC region of IgG to mediate placental transfer

    This allows the antibody to be passed from the mother to the offspring

    This confers mothers immunity p offspring

    In other species the antibodies are acquired from the mother through milk

    Antibodies selectively cross the gastrointestinal tract

    He also used a different enzyme (pepsin) which cut in a different place

    An Fc region containing 2 polypeptide chains F(ab)2

    This was bivalent and could bind 2 antigens

    The variable domain is not uniformly variable

    Thousands of different molecules were studied and the AA sequence was determined

  • 8/7/2019 L3 4 Antibodies

    5/12

    Immunology

    [Page 5]

    Variability was plotted against position

    There are 3 regions ofhypervariability (HV)

    CDR = Complementarity Determining Region

    25-30 CDR1

    50-60 CDR1

    90-95 CDR1

    Complementarity refers to the region that

    determines how an antibody fits to an antigen

    The HV region makes up the binding site,

    antigens obviously have to be very variable in

    this region

    The regions in between are know as the

    framework regions

    Below is a light chain

    Immunoglobulin fold is a defined secondary

    structure element

    Foundin proteins that are part of the immunoglobulin gene superfamily

    Comprised of2F-sheets stabilized by a disulphide bond

    Found in a lot of molecules that are involved in receptor-ligand interactions

    Although in a linear arrangement the CDR are far apart, the folding brings them together at the tip

    The 6 CDRs come

    together to form a

  • 8/7/2019 L3 4 Antibodies

    6/12

    Immunology

    [Page 6]

    binding site for the antigen

    The binding site can accommodate for 6-12 AAs at most

    The antigen makes close contact with the binding site

    The binding is non-covalent, but by a combination of multiple non-covalent bonds

    H-bondsElectrostatic interactionsHydrophobic interactions

    Individually, the attractive forces are weak, but the bonds multiple provided that the antigen fits the site very closely

    (lock + key hypothesis)

    Antigen binds very tightly to the binding site

    Antibodies do no bind all of a molecule, just small regions of it

    e.g. haemaglutinin has 4 / 5 sites for antibody binding

    The site of antibody binding is known as an epitope, usually just a few AAs (~6)

    Continuous epitopes consecutive residues

    Discontinuous epitopes residues that are separate that have been brought together by fold

    A single mutation in the epitope will completely disrupt antibody binding

    This is why new strains of influenza arrive from a single point mutation

    This allows the new strain to escape the immune surveillance

    1st exposure to an antigen = primary immune response2nd exposure to same antigen = secondary immune response

    IgG:

    3 week half-life

    Monomeric one four-chain unit (MW ~160 kDa)

    ~75% of antibody in serum (major serum antibody)

    3 constant domains

    Distributed evenly in the bloodstream as well as throughout the body in tissue fluids

    The major antibody in the secondary immune response

    4 subclasses in humans: IgG 1 4 (different genes for each subclass)

    Subclasses in mice are 1, 2A, 2B & 3

    Numbered in order of concentration (1 is highest, 4 is lowest)

    There are specific FC receptors for each subclass

  • 8/7/2019 L3 4 Antibodies

    7/12

    Immunology

    [Page 7]

    IgM:

    No subclasses

    5 four-chain units (pentameric)

    4 constant domains

    10% serum antibody

    Major antibody involved in the primary immune response

    Primarily restricted to the bloodstream due to its size ~1000

    kDa

    The units are linked by disulphide bonds between the heavy 3

    and 4 domains

    There is an additional polypeptide (137 resides) known as the J

    (joining) chain

    It helps to link all of the subunits together

    It is added during the assembly of the protein in the ER

    Acts as a primary defence against infectious organisms

    Very effective at agglutinating and cross-linking

    The bacteria are clumped together

    IgMhas 10 binding sites for antigens

    2 configurations: star (like in diagram, large distance between binding sites) or staple configuration (in which the

    molecule has some flexibility) There is no hinge region to provide this flexibility, however there is flexion between the

    constant heavy 2 /3 domains. This allows the molecule to sit on a surface with the binding sites oriented in the same

    direction, allowing for strong, multivalent binding.

    IgA:

    2 subclasses: IgA 1 / 2

  • 8/7/2019 L3 4 Antibodies

    8/12

    Immunology

    [Page 8]

    ~15% serum antibody

    May be monomeric or dimeric in serum

    Is the predominant antibody at mucosal surfaces

    Found at high concentrations in the secretions at mucosal surfaces

    e.g. nasopharangeal surfaces, urinogenital tracts etc.

    These surfaces are susceptible to infection (cf. skin)

    Normally dimeric at mucosal surfaces (can be tetramer or trimer also)

    Has a J chain like IgM which is added in the same way

    Also has an additional component: secretory component (a separate polypeptide chain)

    Pathogen enters at lumen

    A plasma cell is a terminally differentiated B-cell

    The plasma cell contains a lot ofER and Golgi as its primary role is to produce a lot of antibodies

    The plasma cells in the submucosa are primarily programmed to make IgA

    1. Plasma cell secretes dimeric IgA

    2. IgA binds to the poly-Ig receptor

    3. Transcytosis occurs; the protein brings the Ig into the cell

    4. During the transport process the receptor is cleaved proteolytically and part of the receptor remains bound to IgA

    this is the secretory component

    The gut is a very hydrolytic environment. The secretory component is thought to protect the antibody from proteolytic

    degradation.

    Some bacteria have evolved to produce proteolytic enzymes that specifically degrade Igs

  • 8/7/2019 L3 4 Antibodies

    9/12

    Immunology

    [Page 9]

  • 8/7/2019 L3 4 Antibodies

    10/12

    Immunology

    [Page 10]

    The gut has specialised lymph nodes known as Peyers patches

    The primary follicles are germinal centres where lymphocytes are dividing

    In the gut, M-cells take up antigens from pathogens

    More in H. Brady lecture

    The plasma cells will migrate within the submucosa and produce IgA which will be translocated across the epithelial

    later, into the lumen to combat the pathogen.

    IgE:

    Very low serum concentration

  • 8/7/2019 L3 4 Antibodies

    11/12

    Immunology

    [Page 11]

    IgE and mast cells have a particular role against helminth (parasitic worm infections)

    IgD:

    Single 4-chain unit

    Not found in serum

    Found on the surface ofB-cells

    An immature B-cell has membrane bound IgM and IgD (both are monomeric)

    Not bound to receptors, the Igs have a short cytoplasmic tail with a hydrophobic region that interacts well with the lipid

    bilayer

    When the B-cell is triggered by an antigen, it will differentiate into a plasma cell that will go on to secrete IgM (IgD is

    not made, thought to only be there as a receptor)

    The IgM that is secreted is modified, it lacks the C-terminal region of the heavy chain by a process of differential

    transcription. Inside the plasma cell, the IgM is polymerised into the pentameric structure and is secreted. This is why

    IgM is the first antibody produced, its production is the first reaction to an antigen.

    Primary Antibody Response:

    It takes around 7 days for antibody levels to reach a peak (IgM)

    IgM is the major antibody in the primary response

    IgG peaks around day 14

    Levels of both will slowly fall

    Decline in antibody conc. is due to the half-life of the antibody,and immune complexes are removed (antibody +

    antigen)

    Secondary Antibody Response:

    When an antigen is encountered for the 2nd + time

    More antigen is produced

    The antigen is produced faster

    IgM response will be similar in terms of amount produced and time to produce it

    IgG response will increase rapidly (3 days) and to a muchhigher level

    IgG is therefore the major antibody in a secondary response

    This is one of the reasons why we have greater protection from a secondary infection

    The antibody affinity (IgG) of binding to antigen will be higher

  • 8/7/2019 L3 4 Antibodies

    12/12

    Immunology

    [Page 12]

    Class switching occurs during the primary immune response. IgMp IgG

    IgM can alsopIgA /E

    Regulation of this is dependent on cytokines

    The variable region stays the same; it is just the heavy chain that is altered

    The binding specificity is maintained, but given to antibodies with different properties

    The higher affinity of binding during the secondary response occurs because during the 2nd infection, mutations occur

    in the hypervariable regions of the antibody (certain regions of the genes are hypermutable) this results in a higher

    binding strength of the antibody for selected mutants. This process is known as affinity maturation. CDR3 is

    particularly hypermutable.

    The selection process occurs as when the antigen is at a low concentration, it will natural select a cell that has an

    antibody with a better fit, therefore these clones will be expanded.

    There are now many more cells that can react to the antigen, but they also have more specific antigens